Edition:
United Kingdom

Insider Trading: Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.62USD
24 Apr 2019
Change (% chg)

$-0.04 (-1.09%)
Prev Close
$3.66
Open
$3.68
Day's High
$3.70
Day's Low
$3.59
Volume
28,232
Avg. Vol
46,472
52-wk High
$6.88
52-wk Low
$2.33

All Insider Trades
Trading Date Name Title Type Shares Traded Price
14 Jan 2019

Rabbani (Elazar)

Chief Executive Officer Buy 2,782 $2.70
14 Jan 2019

Perlysky (Dov)

Director Buy 9,184 $2.70
14 Jan 2019

Weiner (Barry W)

President Buy 2,226 $2.70
14 Jan 2019

Bortz (Gregory M)

Director Buy 9,184 $2.70
29 Oct 2018

Rabbani (Elazar)

Chief Executive Officer Buy 10,000 $3.35
18 Oct 2018

Hanna (Bruce A. Ph.D.)

Director Buy 15,000 $3.52
18 Oct 2018

Perlysky (Dov)

Director Buy 10,000 $3.50
13 Apr 2018

Perlysky (Dov)

Director Buy 81,855 $0.00
12 Apr 2018

Perlysky (Dov)

Director Buy 3,139 $0.00
17 Jan 2018

Weiner (Barry W)

President Sell 11,626 $7.75
17 Jan 2018

Rabbani (Elazar)

Chief Executive Officer Buy 38,505 $2.88
17 Jan 2018

Rabbani (Elazar)

Chief Executive Officer Sell 14,534 $7.75
17 Jan 2018

Weiner (Barry W)

President Sell 11,000 $7.75
17 Jan 2018

Weiner (Barry W)

President Buy 30,802 $2.88
17 Jan 2018

Rabbani (Elazar)

Chief Executive Officer Sell 14,000 $7.75
31 Oct 2017

Perlysky (Dov)

Director Buy 59,455 $2.88
31 Oct 2017

Bortz (Gregory M)

Director Sell 42,005 $9.82
31 Oct 2017

Bortz (Gregory M)

Director Buy 59,455 $2.88
31 Oct 2017

Perlysky (Dov)

Director Sell 42,000 $9.81
27 Oct 2017

O Brien (James Michael)

Officer Sell 7,500 $10.28
27 Oct 2017

O Brien (James Michael)

Officer Buy 7,500 $3.40
27 Oct 2017

O Brien (James Michael)

Officer Sell 6,699 $10.28
27 Oct 2017

O Brien (James Michael)

Officer Buy 6,699 $2.75
27 Oct 2017

O Brien (James Michael)

Officer Buy 8,667 $4.35
27 Oct 2017

O Brien (James Michael)

Officer Sell 8,667 $10.28

Institutional Holders

% Shares Owned: 75.78%
# of Holders: 114
Total Shares Held: 35,799,876
3 Mo. Net Change: 2,457,853
# New Positions: 1
# Closed Positions: 4
# Increased Positions: 5
# Reduced Positions: 11
# Net Buyers: -6

Officers & Directors

Name Age Since Current Position

Barry Weiner

68 2009 President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Director

Elazar Rabbani

75 2009 Chairman of the Board, Chief Executive Officer, Secretary

James O'Brien

52 2015 Executive Vice President - Finance

Bruce Dey

60 2016 Vice President - Sales and Marketing, Enzo Clinical Labs

Dieter Schapfel

55 2014 Chief Medical Director,

Gregory Bortz

49 2017 Lead Independent Director

Bruce Hanna

75 2017 Independent Director

Dov Perlysky

56 2012 Independent Director

Steve Anreder

IR Contact Officer